Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neeraj Narula

Showing results (141-150 of 204) with videos related to

Pageof 21
Sort By:
Journal of Clinical Gastroenterology|October 13, 2022
Baseline Patient-reported Symptoms Less Predictive Than MM-SES-CD for Endoscopic Remission in Crohn's DiseaseNeeraj Narula, Emily C L Wong, Achuthan Aruljothy, et al.
Inflammatory Bowel Diseases|July 26, 2022
Increased Expression of Interleukin-13 Receptor in Ileum Associated With Nonresponse to Adalimumab in Ileal Crohn's DiseaseEmily C L Wong, Arif Yusuf, Jagoda Pokryszka, et al.
The American Journal of Gastroenterology|April 3, 2026
An Enhanced Treatment Algorithm Targeting Mucosal Healing is Effective and Safe in Older Patients with Crohn's Disease: A Post-hoc Analysis of the REACT2 TrialShane W Goodwin, Sudheer Kumar Vuyyuru, Rocio Sedano, et al.
Alimentary Pharmacology & Therapeutics|November 4, 2025
Meta-Analysis: Improvement of Bowel Urgency With Advanced Therapies for Inflammatory Bowel DiseasePurab Patel, Peter Belesiotis, Nitin Shiv Rai, et al.
Journal of Crohn'S & Colitis|February 8, 2022
Categorising Endoscopic Severity of Crohn's Disease Using the Modified Multiplier SES-CD [MM-SES-CD]Neeraj Narula, Cara Pray, Emily C L Wong, et al.
Journal of Crohn'S & Colitis|October 19, 2021
Early Reduction in MM-SES-CD Score After Initiation of Biologic Therapy is Highly Specific for 1-year Endoscopic Remission in Moderate to Severe Crohn's DiseaseNeeraj Narula, Emily C L Wong, Jean-Frederic Colombel, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 2, 2023
Food Processing and Risk of Inflammatory Bowel Disease: A Systematic Review and Meta-AnalysisNeeraj Narula, Nicole H Chang, Danah Mohammad, et al.
Journal of Crohn'S & Colitis|June 26, 2026
The impact of global recruitment and country income on placebo rates in inflammatory bowel disease clinical trialsShane W Goodwin, Yuhong Yuan, Siddharth Singh, et al.
Journal of Crohn'S & Colitis|November 7, 2023
Pharmacological Therapies for the Management of Fistulizing Crohn's Disease: A Systematic Review and Meta-AnalysisSudheer K Vuyyuru, Virginia Solitano, Neeraj Narula, et al.
Eclinicalmedicine|July 23, 2025
Impact of diet on inflammatory bowel disease risk: systematic review, meta-analyses and implications for preventionAntoine Meyer, Manasi Agrawal, Einat Savin-Shalom, et al.
Pageof 21

Showing results (141-150 of 204) with videos related to

Sort By:
Pageof 21
Journal of Clinical Gastroenterology|October 13, 2022
Baseline Patient-reported Symptoms Less Predictive Than MM-SES-CD for Endoscopic Remission in Crohn's DiseaseNeeraj Narula, Emily C L Wong, Achuthan Aruljothy, et al.
Inflammatory Bowel Diseases|July 26, 2022
Increased Expression of Interleukin-13 Receptor in Ileum Associated With Nonresponse to Adalimumab in Ileal Crohn's DiseaseEmily C L Wong, Arif Yusuf, Jagoda Pokryszka, et al.
The American Journal of Gastroenterology|April 3, 2026
An Enhanced Treatment Algorithm Targeting Mucosal Healing is Effective and Safe in Older Patients with Crohn's Disease: A Post-hoc Analysis of the REACT2 TrialShane W Goodwin, Sudheer Kumar Vuyyuru, Rocio Sedano, et al.
Alimentary Pharmacology & Therapeutics|November 4, 2025
Meta-Analysis: Improvement of Bowel Urgency With Advanced Therapies for Inflammatory Bowel DiseasePurab Patel, Peter Belesiotis, Nitin Shiv Rai, et al.
Journal of Crohn'S & Colitis|February 8, 2022
Categorising Endoscopic Severity of Crohn's Disease Using the Modified Multiplier SES-CD [MM-SES-CD]Neeraj Narula, Cara Pray, Emily C L Wong, et al.
Journal of Crohn'S & Colitis|October 19, 2021
Early Reduction in MM-SES-CD Score After Initiation of Biologic Therapy is Highly Specific for 1-year Endoscopic Remission in Moderate to Severe Crohn's DiseaseNeeraj Narula, Emily C L Wong, Jean-Frederic Colombel, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 2, 2023
Food Processing and Risk of Inflammatory Bowel Disease: A Systematic Review and Meta-AnalysisNeeraj Narula, Nicole H Chang, Danah Mohammad, et al.
Journal of Crohn'S & Colitis|June 26, 2026
The impact of global recruitment and country income on placebo rates in inflammatory bowel disease clinical trialsShane W Goodwin, Yuhong Yuan, Siddharth Singh, et al.
Journal of Crohn'S & Colitis|November 7, 2023
Pharmacological Therapies for the Management of Fistulizing Crohn's Disease: A Systematic Review and Meta-AnalysisSudheer K Vuyyuru, Virginia Solitano, Neeraj Narula, et al.
Eclinicalmedicine|July 23, 2025
Impact of diet on inflammatory bowel disease risk: systematic review, meta-analyses and implications for preventionAntoine Meyer, Manasi Agrawal, Einat Savin-Shalom, et al.
Pageof 21